Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Int J Pharm ; 581: 119289, 2020 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-32243968

RESUMO

Proteins represent a group of biopolymers with interesting properties to be employed as raw materials in the preparation of nanoparticles for drug delivery purposes. Due to the inherent properties of proteins (i.e., biodegradability, amphiphilic properties, etc.) the resulting nanoparticles can be considered as versatility platforms for a variety of applications. Moreover, some proteins possess a GRAS (Generally Recognized as Safe) status or are considered as excipients by different Regulatory Agencies. As result of this, the resulting nanoparticles and potential translation to clinic would be facilitated, compared to other materials (i.e., polymers). This review is focused on the main proteins employed in the preparation of nanoparticles as well as the procedures permitting their transformation into nanoparticles able of accommodating a high variety of bioactive compounds and drugs. Moreover, the review also provides examples of application of nanoparticles prepared from albumins, globulins, prolamins or macromolecules derived from proteins.


Assuntos
Albuminas/química , Sistemas de Liberação de Medicamentos/métodos , Globulinas/química , Nanopartículas/química , Prolaminas/química , Albuminas/administração & dosagem , Albuminas/metabolismo , Animais , Caseínas/administração & dosagem , Caseínas/química , Caseínas/metabolismo , Portadores de Fármacos/administração & dosagem , Portadores de Fármacos/química , Portadores de Fármacos/metabolismo , Sistemas de Liberação de Medicamentos/tendências , Globulinas/administração & dosagem , Globulinas/metabolismo , Humanos , Nanopartículas/administração & dosagem , Nanopartículas/metabolismo , Prolaminas/administração & dosagem , Prolaminas/metabolismo , Zeína/administração & dosagem , Zeína/química , Zeína/metabolismo
2.
Clin Nutr ; 36(1): 275-280, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-26714791

RESUMO

BACKGROUND/OBJECTIVES: Adherence to gluten-free diet in self reported non-coeliac gluten sensitive subjects is scarcely researched. Objectives of the study were to compare dietary adherence in coeliac disease (CD) subjects and in non-coeliac gluten sensitive (NCGS) subjects, and to estimate gluten exposure based on weighed food records and analysis of gluten content in selected food items. SUBJECTS/METHODS: Twenty-three subjects with biopsy verified CD on a gluten-free diet and 34 HLA-DQ2+ NCGS subjects on a self-instituted gluten-free diet were enrolled. The latter group was under investigation of CD. Dietary adherence was assessed by frequency questionnaire and structured forms supplied by weighed food records. For the analyses of food samples, the sandwich R5-ELISA, Ridascreen® Gliadin competitive method was used. RESULTS: There was no difference in dietary adherence between CD and NCGS subjects (83% vs 68%, p = 0.21). NCGS subjects were mainly self-educated in gluten-free diet compared to CD subjects (91% and 39%, respectively, p < 0.001). In non-adherent subjects, there was no difference in gluten exposure between CD and NCGS (10 vs 138 mg/day, p = 0.83). There was no difference in BMR-factor between CD and NCGS subjects, or between adherent and non-adherent subjects. CONCLUSIONS: Both CD and NCGS subjects were largely adherent, and adherence did not differ between the groups. Gluten exposure varied greatly, and some CD and NCGS subjects reached gluten intake above 500 mg/day, which might have considerable health effects on the individual, especially in case of coeliac disease.


Assuntos
Doença Celíaca/dietoterapia , Dieta Livre de Glúten , Glutens/administração & dosagem , Síndromes de Malabsorção/dietoterapia , Cooperação do Paciente , Adolescente , Adulto , Idoso , Índice de Massa Corporal , Grão Comestível/química , Feminino , Hipersensibilidade Alimentar/diagnóstico , Hipersensibilidade Alimentar/dietoterapia , Antígenos HLA-DQ/genética , Humanos , Masculino , Pessoa de Meia-Idade , Avaliação Nutricional , Prolaminas/administração & dosagem , Autorrelato , Adulto Jovem
3.
Adv Food Nutr Res ; 57: 235-85, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19595389

RESUMO

Celiac disease is an immune-mediated disease, triggered in genetically susceptible individuals by ingested gluten from wheat, rye, barley, and other closely related cereal grains. The only treatment for celiac disease is a strict gluten-free diet for life. This paper presents a systematic review of the scientific literature on the safety of pure oats for individuals with celiac disease, which historically has been subject to debate. Limitations identified within the scientific database include: limited data on long-term consumption, limited numbers of participants in challenge studies, and limited reporting about the reasons for withdrawals from study protocols. Furthermore, some evidence suggests that a small number of individuals with celiac disease may be intolerant to pure oats and some evidence from in vitro studies suggests that an immunological response to oat avenins can occur in the absence of clinical manifestations of celiac disease as well as suggesting that oat cultivars vary in toxicity. Based on the majority of the evidence provided in the scientific database, and despite the limitations, Health Canada and the Canadian Celiac Association (CCA) concluded that the majority of people with celiac disease can tolerate moderate amounts of pure oats. The incorporation of oats into a gluten-free diet provides high fiber and vitamin B content, increased palatability, and beneficial effects on cardiovascular health. However, it is recommended that individuals with celiac disease should have both initial and long-term assessments by a health professional when introducing pure oats into a gluten-free diet.


Assuntos
Avena/efeitos adversos , Doença Celíaca/dietoterapia , Doença Celíaca/imunologia , Dieta Livre de Glúten , Sementes/química , Adulto , Avena/química , Avena/imunologia , Criança , Ensaios Clínicos como Assunto , Dermatite Herpetiforme/dietoterapia , Dermatite Herpetiforme/imunologia , Alimento Funcional/efeitos adversos , Glutens/toxicidade , Humanos , Valor Nutritivo , Prolaminas/administração & dosagem , Prolaminas/efeitos adversos , Prolaminas/química , Prolaminas/imunologia , Controle de Qualidade , Especificidade da Espécie
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA